MoonLake Immunotherapeutics Other Current Assets

MoonLake Immunotherapeutics (MLTX) currently reports a other current assets of $33M as of March 2026. That compares with $23M in the prior-year period — up 42.4% year over year. Use the charts on this page to explore MoonLake Immunotherapeutics's other current assets history and peer comparisons.

MoonLake Immunotherapeutics's other current assets increased from $23M to $33M — a 42.4% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

MoonLake Immunotherapeutics reported $33M in other current assets as of March 2026. That compares with $23M in the prior-year period — up 42.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $33M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for MoonLake Immunotherapeutics, and consider following MLTX for alerts when major investors trade the stock.